STOK
#2056
Stoke Therapeutics, Inc. - Common Stock
29.4 6 USD
-0.06%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-6.12%
Monthly Change
-3.38%
6 month change
-5.39%
Year Change
+143.27%
Previous Close
31.3 8
Open
29.4 6
Low
29.4 6
High
29.4 6
Volume
112
Financials
- Market Capitalization 1.83 B
- Employee 170
- Founded 2014
- CEO N/A
- Website www.stoketherapeutics.com
- Headquarter Delaware, United States
- FIGI BBG00JPCBPG9
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-264.5
Price to sales ratio
10.19
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2044 |  BCAX Bicara Therapeutics Inc. - Common Stock | 28.15 USD | -2.63% | -4.41% | +28.36% | +94.94% | 1.85 B USD | ||
| 2051 |  PGEN Precigen, Inc. - Common Stock | 5.17 USD | -2.82% | -8.17% | +12.39% | +163.78% | 1.84 B USD | ||
| 2057 |  AAPG Ascentage Pharma Group International - American Depository Shar | 19.62 USD | -1.75% | +6.05% | +9.18% | -21.52% | 1.83 B USD | ||
| 2059 |  ATAI AtaiBeckley Inc. - Common Stock | 4.97 USD | -3.87% | -1.00% | +24.56% | +25.82% | 1.83 B USD |
Frequently asked questions about Stoke Therapeutics, Inc. - Common Stock
What is the Stoke Therapeutics, Inc. - Common Stock stock price today?
The current price of Stoke Therapeutics, Inc. - Common Stock (STOK) is 29.46. Over the past 24 hours, the stock has changed by -6.12%. Follow the STOK chart for real-time price dynamics.
What is the stock ticker of Stoke Therapeutics, Inc. - Common Stock?
Stoke Therapeutics, Inc. - Common Stock trades under the ticker STOK. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Stoke Therapeutics, Inc. - Common Stock stock going up?
STOK has changed by -10.24% over the last week, -3.38% over the last month, and +143.27% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Stoke Therapeutics, Inc. - Common Stock net income for the last quarter?
Stoke Therapeutics, Inc. - Common Stock reported net income of -50 M for the last quarter. The previous quarter showed -57.93 M, which means net income changed by +13.69%.
How many employees does Stoke Therapeutics, Inc. - Common Stock have?
As of the latest available data, Stoke Therapeutics, Inc. - Common Stock has 170 employees. Workforce size can provide additional context about the company's scale and operations.
What is Stoke Therapeutics, Inc. - Common Stock EBITDA?
Stoke Therapeutics, Inc. - Common Stock EBITDA is -52.98 M, and its EBITDA margin is -850.52%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Stoke Therapeutics, Inc. - Common Stock stock?
You can buy Stoke Therapeutics, Inc. - Common Stock (STOK) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Stoke Therapeutics, Inc. - Common Stock stock?
Investing in Stoke Therapeutics, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the STOK chart and related analysis on metatrader.com as part of your research.